EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,102,373 | – | 38,857 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 4,780,188 | $353,877,000 | 83.76% |
JW Asset Management, LLC | 848,709 | $62,830,000 | 22.76% |
Consonance Capital Management LP | 1,353,913 | $100,230,000 | 14.10% |
Cormorant Asset Management, LP | 300,000 | $22,209,000 | 3.55% |
Park West Asset Management LLC | 500,591 | $37,059,000 | 3.38% |
Opaleye Management Inc. | 73,200 | $5,419,000 | 2.67% |
Ranger Investment Management | 428,295 | $31,707,000 | 1.79% |
WALL STREET ASSOCIATES | 119,900 | $8,876,000 | 1.70% |
Timpani Capital Management LLC | 27,090 | $2,005,000 | 0.81% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 22,375 | $1,656,000 | 0.79% |